Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

Medable recently introduced AI features within its clinical trial platform, Medable Studio, aimed at accelerating digital and ...

While these sites are important for clinical research, they make patient recruitment challenging. Many participants are ...

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Innovative radiotherapy offers a precision treatment alternative.

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% ...

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

The Boston-based startup Axonis Therapeutics has bagged $115 million in a Series A round to fuel its pipeline of treatments for pain, epilepsy and other conditions.

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.